Predicative Biomarkers Of Response To Immunotherapy In Sts

Brian Van Tine, MD, PhD, Washington University, St. Louis, MO, comments on biomarker research in the Phase II trial (NCT04551430) of cabozantinib with nivolumab and ipilimumab in patients with metastatic soft tissue sarcoma (STS). Analysis of patient biopsies with RNA-seq will enable the identification of biomarkers that will enable clinicians to find patients who will respond treatment. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

  • Predicative biomarkers of response to immunotherapy in STS ( Download)
  • Unesbulin plus dacarbazine demonstrates promising efficacy in patients with advanced leiomyosarcoma ( Download)
  • Spearhead 1 Study ( Download)
  • Toronto Cardiac Tumor Conference 2020 Brian Van Tine ( Download)
  • Treating early-stage TNBC ( Download)
  • WEBINAR | Review of hot topics in Regulatory & Safety + Outlook into 2024 ( Download)

Author

Ariyani

Como educador, estou profundamente engajado no desenvolvimento dos estudantes em ambiente escolar, adotando métodos pedagógicos que valorizam conexões genuínas e são movidos por inovação e fervor. É minha vocação guiar os alunos na jornada de se tornarem uma geração notável, empregando estratégias de ensino amplamente aclamadas por prestigiadas instituições acadêmicas ao redor do globo - events.zulekhahospitals.com